+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Immune Thrombocytopenia Market Report and Forecast 2024-2032 - Product Thumbnail Image

Immune Thrombocytopenia Market Report and Forecast 2024-2032

  • Report
  • October 2024
  • 200 Pages
  • Global
From
Leukemia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Leukemia Therapeutics - Global Strategic Business Report

  • Report
  • May 2025
  • 193 Pages
  • Global
From
Secondary Hyperparathyroidism - Pipeline Insight, 2025 - Product Thumbnail Image

Secondary Hyperparathyroidism - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Postmenopausal Osteoporosis Treatment Market Report 2025 - Product Thumbnail Image

Postmenopausal Osteoporosis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
Chemotherapy-induced Thrombocytopenia (CIT) - Pipeline Insight, 2025 - Product Thumbnail Image

Chemotherapy-induced Thrombocytopenia (CIT) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Neutropenia Biologic Drug Treatment Market Report 2025 - Product Thumbnail Image

Neutropenia Biologic Drug Treatment Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
Loading Indicator